Immix Biopharma, Inc.

IMMX • NASDAQ • Stock Fundamentals

Immix Biopharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ilya Rachman, with a market cap of $576.6M.

Market Cap$576.6M

Employees17.0

CEOIlya Rachman

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 14, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Immix Biopharma, Inc.

Immix Biopharma, Inc. (IMMX) has a market capitalization of $576.6M and trades on NASDAQ.

Immix Biopharma, Inc. has approximately 17 employees.